Levosimendan, an amazing organ protector in acute heart failure, is currently not
recommended in the events of moderate-to-severe renal impairment and shock. We report …

Background Levosimendan can improve clinical symptoms and the cardiorenal rescue
success rate, and stabilize hemodynamic parameters in individuals suffering from acute …

Background The inodilator levosimendan has shown improved outcomes in acute heart
failure (AHF) and cardiac surgery. Its hemodynamic effect is persistent, owing to a long (70 …

Background Acute heart failure is a life-threatening clinical condition. Levosimendan is an
effective inotropic agent used to maintain cardiac output, but its usage is limited by the lack …

Purpose The purpose of this study is to describe the effect of levosimendan (without loading
dose) on hemodynamics, inotropes/vasopressors, and mortality in acute heart failure (AHF) …

Background Patients with heart failure frequently present with kidney dysfunction. Kidney
function is relevant, as prognosis declines with reduced kidney function and potentially …

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Despite
recent advances, acute heart failure poses a therapeutic challenge due to its high morbidity …

Aims Levosimendan improves haemodynamics in acute decompensated heart failure (HF).
However, it is increasingly used for repetitive or intermittent infusions in advanced but stable …

Objective: To investigate the indication, effectiveness, tolerance, and safety of levosimendan
in patients with acute heart failure (AHF) in 20 hospitals in Beijing, China. Methods: This …

BACKGROUND: Long-term impact of levosimendan on renal function remains undefined.
Prospectively, we evaluated effects of levosimendan on renal function in patients with …